Europe alpha-1 antitrypsin deficiency (AATD) augmentation therapy market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is expected to reach USD 317.65 million by 2029 from USD 179.24 million in 2021, growing with a CAGR of 8.3% in the forecast period of 2022 to 2029. The large scale EUROPE ALPHA-1 ANTITRYPSIN...